Bioxytran, Inc financial data

Symbol
BIXT on OTC
Location
C/O Bioxytran, Inc., 75 2 Nd Ave, Suite 605 Ste 605, Needham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.54 % -67.1%
Return On Equity 120 % -36.5%
Return On Assets -1.69K % +28.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 89M shares -50%
Common Stock, Shares, Outstanding 89M shares -49.8%
Entity Public Float 8M USD -13%
Common Stock, Value, Issued 89K USD -49.8%
Weighted Average Number of Shares Outstanding, Basic 88.8M shares -49.7%
Weighted Average Number of Shares Outstanding, Diluted 88.8M shares -49.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 103K USD
General and Administrative Expense 647K USD -34%
Operating Income (Loss) -1.57M USD +53.5%
Nonoperating Income (Expense) 260K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.46M USD +30.3%
Net Income (Loss) Attributable to Parent -2.46M USD +28.9%
Earnings Per Share, Basic 0 USD/shares -300%
Earnings Per Share, Diluted 0 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 3.14K USD -76.7%
Assets 148K USD +14.7%
Accounts Payable, Current 201K USD
Liabilities, Current 2.78M USD +127%
Liabilities 2.78M USD +127%
Retained Earnings (Accumulated Deficit) -20.2M USD -19.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.64M USD -140%
Liabilities and Equity 148K USD +14.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -167K USD -52.7%
Net Cash Provided by (Used in) Financing Activities 167K USD +67.4%
Net Cash Provided by (Used in) Investing Activities -6K USD -27.3%
Common Stock, Shares Authorized 400M shares +33.3%
Common Stock, Shares, Issued 89M shares -49.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 164K USD +212%
Deferred Tax Assets, Valuation Allowance 3.28M USD +19.3%
Deferred Tax Assets, Gross 3.28M USD +19.3%
Deferred Tax Assets, Operating Loss Carryforwards 15.6M USD +19.3%
Preferred Stock, Shares Issued 43.4M shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 17.5M USD +6.69%
Preferred Stock, Shares Outstanding 43.4M shares
Amortization of Intangible Assets 8.74K USD -4.45%
Share-based Payment Arrangement, Expense 28.6K USD -90.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%